Hsiao-Ching Li

  • 75 Citations
  • 4 h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Hsiao-Ching Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Quinazolinones Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Purines Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Local Neoplasm Recurrences Medicine & Life Sciences
Antineoplastic Agents Medicine & Life Sciences
Safety-net Providers Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 75 Citations
  • 4 h-Index
  • 16 Article
  • 1 Comment/debate
  • 1 Editorial
  • 1 Letter
1 Citation (Scopus)

Clinicopathologic features, management, and outcomes of plasmablastic lymphoma: A 10-year experience

Arora, N., Eule, C., Gupta, A., Li, H-C. & Sadeghi, N., May 1 2019, In : American Journal of Hematology. 94, 5, p. E127-E129

Research output: Contribution to journalLetter

antineoplaston A10
Plasmablastic Lymphoma

Decreasing Inappropriate Use of Rasburicase to Promote Cost-Effective Care

Patel, K. K., Brown, T. J., Gupta, A., Roberts, T., Marley, E., Li, H. C. & Sadeghi, N., Feb 1 2019, In : Journal of oncology practice. 15, 2, p. e178-e186

Research output: Contribution to journalArticle

Costs and Cost Analysis
Tumor Lysis Syndrome
Quality Improvement
Prescriptions
rasburicase

Reducing Hospitalizations: Institution of Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net Hospital

Keshvani, N., Hon, M., Gupta, A., Brown, T. J., Roy, L., Marley, E., Lindsey, S., Johnson, D. H., Sadeghi, N. & Li, H. C., Aug 1 2019, In : Journal of oncology practice. 15, 8, p. e644-e651

Research output: Contribution to journalArticle

Safety-net Providers
Hospitalization
Outpatients
Drug Therapy
Inpatients
3 Citations (Scopus)

Applying the 'COST' (Culture, Oversight, Systems Change, and Training) Framework to De-Adopt the Neutropenic Diet

Gupta, A., Brown, T. J., Singh, S., Sen, A., Agrawal, D., Li, H. C., Moriates, C., Johnson, D. H. & Sadeghi, N., Jan 1 2018, (Accepted/In press) In : American Journal of Medicine.

Research output: Contribution to journalArticle

Diet
3 Citations (Scopus)
radiation therapy
Lymphoma
Radiotherapy
chemotherapy
progressions